EP0119737A3 - Arzneimittel und dessen Herstellung - Google Patents

Arzneimittel und dessen Herstellung Download PDF

Info

Publication number
EP0119737A3
EP0119737A3 EP84300967A EP84300967A EP0119737A3 EP 0119737 A3 EP0119737 A3 EP 0119737A3 EP 84300967 A EP84300967 A EP 84300967A EP 84300967 A EP84300967 A EP 84300967A EP 0119737 A3 EP0119737 A3 EP 0119737A3
Authority
EP
European Patent Office
Prior art keywords
production
pharmaceutical composition
integer
compound
dient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP84300967A
Other languages
English (en)
French (fr)
Other versions
EP0119737A2 (de
Inventor
Shin-Ichiro 201-202 Gouchi Hirai
Kumiko Jono
Hisayoshi Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of EP0119737A2 publication Critical patent/EP0119737A2/de
Publication of EP0119737A3 publication Critical patent/EP0119737A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP84300967A 1983-02-17 1984-02-15 Arzneimittel und dessen Herstellung Withdrawn EP0119737A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58025979A JPS59152320A (ja) 1983-02-17 1983-02-17 水性製剤
JP25979/83 1983-02-17

Publications (2)

Publication Number Publication Date
EP0119737A2 EP0119737A2 (de) 1984-09-26
EP0119737A3 true EP0119737A3 (de) 1985-10-16

Family

ID=12180841

Family Applications (1)

Application Number Title Priority Date Filing Date
EP84300967A Withdrawn EP0119737A3 (de) 1983-02-17 1984-02-15 Arzneimittel und dessen Herstellung

Country Status (2)

Country Link
EP (1) EP0119737A3 (de)
JP (1) JPS59152320A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
JPH0660101B2 (ja) * 1984-11-27 1994-08-10 参天製薬株式会社 クロベタゾン−１７−ブチレ−トの水性製剤
JPS61191623A (ja) * 1985-02-20 1986-08-26 Green Cross Corp:The 易吸収性医薬組成物
JPS61207380A (ja) * 1985-03-11 1986-09-13 Taiyo Yakuhin Kogyo Kk モベンゾキサミンの経口製剤
DE3678356D1 (de) * 1985-08-06 1991-05-02 Kao Corp Fluessige shampoozusammensetzung.
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JPS6272688A (ja) * 1985-09-25 1987-04-03 Ss Pharmaceut Co Ltd 鎮咳去痰組成物
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
CA2031469A1 (en) * 1989-12-28 1991-06-29 Larry A. Wheeler Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension
FR2738149B1 (fr) * 1995-09-06 1997-11-14 Chauvin Lab Sa Collyre a base d'indometacine pret a l'emploi
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
ATE252369T1 (de) * 1996-08-09 2003-11-15 Alcon Mfg Ltd Konservierungssysteme fur cyclodextrine enthaltende arzneimittel
EP1109581A1 (de) 1998-09-02 2001-06-27 Allergan Sales, Inc. Geschützte cyclodextrin-enthaltende zusammensetzungen
LT1713504T (lt) * 2004-01-30 2017-09-11 Zoetis Services Llc Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
US10959962B2 (en) * 2019-02-15 2021-03-30 Saol International Development Ltd. Injectable phenol formulations and methods of their use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943793C (de) * 1955-03-16 1956-06-01 Kade Pharmazeutische Fabrik Dr Verfahren zur Herstellung eines Mittels zur Behandlung von Brandwunden
GB2048917A (en) * 1979-04-23 1980-12-17 Richter Gedeon Vegyeszet Inclusion complexes of 1- phenyl-1-(3-trifluoromethylphenyl)- propanol-1 with cyclodextrins, their preparation and pharmaceutical compositions containing them
EP0094157A1 (de) * 1982-04-30 1983-11-16 Takeda Chemical Industries, Ltd. Pharmazeutische Zusammensetzung und ihre Verwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943793C (de) * 1955-03-16 1956-06-01 Kade Pharmazeutische Fabrik Dr Verfahren zur Herstellung eines Mittels zur Behandlung von Brandwunden
GB2048917A (en) * 1979-04-23 1980-12-17 Richter Gedeon Vegyeszet Inclusion complexes of 1- phenyl-1-(3-trifluoromethylphenyl)- propanol-1 with cyclodextrins, their preparation and pharmaceutical compositions containing them
EP0094157A1 (de) * 1982-04-30 1983-11-16 Takeda Chemical Industries, Ltd. Pharmazeutische Zusammensetzung und ihre Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
H.P. FIEDLER: "Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete", 2nd edition, vol. 1, 1981, pages 237,240, Editio Cantor, Aulendorf, (DE) *

Also Published As

Publication number Publication date
JPS59152320A (ja) 1984-08-31
EP0119737A2 (de) 1984-09-26

Similar Documents

Publication Publication Date Title
EP0119737A3 (de) Arzneimittel und dessen Herstellung
MY101353A (en) Arylcarboxylic acid derivatives, the preparation and use thereof.
EP0226441A3 (de) Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Hypoxie
EP0270362A3 (de) Pyridinyl-Pyrimidin-Derivate, Verfahren zu deren Herstellung und diese als wirksamen Stoff enthaltendes fungicides Mittel
EP0317959A3 (de) Zusammensetzung gegen Geschwüre
EP0277384A3 (de) 1H-Imidazol-5-Kohlensäurederivate
EP0279523A3 (de) Carbonsäure enthaltende Läuse tötende Zusammensetzungen
HU171226B (hu) Insekticidnye, akaricidnye i fungicidnye kompozicii, i sposob poluchenija proizvodnykh amidokarbonil-tiobarbiturovojj kisloty i soli primenimykh aktivnymi agentami
EP0327709A3 (de) Platin-Komplex, diesen enthaltendes antineoplastisches Agens, Zwischenprodukt, Verfahren zur Herstellung und Verwendung
IE801220L (en) Pyridopyrimidines
EP0194901A3 (de) Derivate des Isoprenoidamines, Zusammensetzungen die diese enthalten, ihre Herstellung und Verwendung
FR2293147A1 (fr) Composition fongicide pour l'agriculture ayant comme ingredient actif une 4-(3'-5'-dichlorophenyl)urazole
EP0207497A3 (de) Chinoloncarbonsäurederivat und Verfahren zu seiner Herstellung
EP0209843A3 (de) Benzylpiperazin-Verbindung, deren Herstellung, pharmazeutische Zusammensetzung und Verwendung
EP0228035A3 (de) Antimikrobische 1-thienyl-4-oxochinolin-3-carbonsäure-Verbindungen
EP0364943A3 (de) Benzoheterozyklische Verbindungen
JPS57156464A (en) Imidazole derivative and agricultural and horticultural germicide
ES8701185A1 (es) Un procedimiento para preparar un complejo metalico farma- ceuticamente aceptable de un compuesto bis-indolico
GB1421562A (en) Pesticidal thiophosphoric acid esters
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
JPS57203067A (en) Novel quinolinecarboxylic acid derivatives, their preparations, and antibacterial agent comprising them as active ingredient
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
EP0304858A3 (de) Cephemverbindungen, ihre Herstellung und Anwendung
ES8504736A1 (es) Un procedimiento para la preparacion de compuestos de imidazolilpropanol opticamente activos
IE822504L (en) Pyrimidine derivative.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): BE CH DE FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): BE CH DE FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19860325

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19861023

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HIRAI, SHIN-ICHIRO201-202 GOUCHI

Inventor name: JONO, KUMIKO

Inventor name: SHIMIZU, HISAYOSHI